You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

DOXYCYCLINE HYCLATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Doxycycline Hyclate, and when can generic versions of Doxycycline Hyclate launch?

Doxycycline Hyclate is a drug marketed by Pliva, Bausch, Actavis Labs Fl Inc, Ajanta Pharma Ltd, Alembic, Amneal Pharms, Changzhou Pharm, Chartwell, Halsey, Heather, Hikma Intl Pharms, Interpharm, Mutual Pharm, Nesher Pharms, Nostrum Labs Inc, Par Pharm, Pvt Form, Ranbaxy, Strides Pharma, Sun Pharm Industries, Superpharm, Warner Chilcott, Watson Labs, Zhejiang Yongtai, Zydus Lifesciences, Gland Pharma Ltd, Par Sterile Products, West-ward Pharms Int, Actavis Elizabeth, Aurobindo Pharma Usa, Heritage Pharms, Impax Labs Inc, Lupin, Prinston Inc, Rising, Zydus Pharms, Acella, Amneal, Amneal Pharms Co, Apotex, Avet Lifesciences, Caribe Holdings, Chartwell Molecular, Dr Reddys Labs Sa, Epic Pharma Llc, Heritage Pharma, Larken Labs, Lupin Ltd, Mylan, Novel Labs Inc, Pharmobedient, and Praxgen. and is included in seventy-six NDAs.

The generic ingredient in DOXYCYCLINE HYCLATE is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-two suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Doxycycline Hyclate

A generic version of DOXYCYCLINE HYCLATE was approved as doxycycline hyclate by CARIBE HOLDINGS on November 8th, 1982.

  Try a Trial

Drug patent expirations by year for DOXYCYCLINE HYCLATE
Drug Prices for DOXYCYCLINE HYCLATE

See drug prices for DOXYCYCLINE HYCLATE

Drug Sales Revenue Trends for DOXYCYCLINE HYCLATE

See drug sales revenues for DOXYCYCLINE HYCLATE

Recent Clinical Trials for DOXYCYCLINE HYCLATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The Jinnah Postgraduate Medical Centre, Rafiqui، Sarwar Shaheed Rd, Karachi Cantonment, Karachi, Karachi City, Sindh 75510Phase 1/Phase 2
University of KarachiPhase 1/Phase 2
The Jinnah Postgraduate Medical Centre, Karachi, Sindh 75510, PakistanPhase 1/Phase 2

See all DOXYCYCLINE HYCLATE clinical trials

Pharmacology for DOXYCYCLINE HYCLATE
Paragraph IV (Patent) Challenges for DOXYCYCLINE HYCLATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
DORYX MPC Delayed-release Tablets doxycycline hyclate 60 mg and 120 mg 050795 1 2017-09-28
DORYX MPC Delayed-release Tablets doxycycline hyclate 50 mg 050795 1 2015-11-05
DORYX MPC Delayed-release Tablets doxycycline hyclate 80 mg 050795 1 2015-07-01
DORYX MPC Delayed-release Tablets doxycycline hyclate 200 mg 050795 1 2014-05-19
DORYX MPC Delayed-release Tablets doxycycline hyclate 150 mg 050795 1 2008-12-19

US Patents and Regulatory Information for DOXYCYCLINE HYCLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin DOXYCYCLINE HYCLATE doxycycline hyclate TABLET, DELAYED RELEASE;ORAL 208741-003 Aug 11, 2023 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 209243-001 Apr 15, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Warner Chilcott DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062594-001 Dec 5, 1985 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pvt Form DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062631-002 Jul 24, 1986 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms DOXYCYCLINE HYCLATE doxycycline hyclate TABLET, DELAYED RELEASE;ORAL 206772-001 Dec 21, 2018 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Epic Pharma Llc DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 214207-002 Dec 16, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.